share_log

Argus Research Upgrades Silk Road Medical to Buy, Announces $24 Price Target

Argus Research Upgrades Silk Road Medical to Buy, Announces $24 Price Target

阿格斯研究将丝路医疗上调为买入,宣布目标股价为24美元
Benzinga ·  03/07 10:43

Argus Research analyst Steve Silver upgrades Silk Road Medical (NASDAQ:SILK) from Hold to Buy and announces $24 price target.

阿格斯研究分析师史蒂夫·西尔弗将丝路医疗(纳斯达克股票代码:SILK)从 “持有” 上调至 “买入”,并宣布目标股价为24美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发